Beijing business signs up for dispatch (the horse changes reporter Meng Fanxia) on May 20 evening, haing drug stock (600664) releases announcement to say, the company receives subsidiary to breath out limited company of engineering of medical group living things (the following abbreviation " biology project " ) with world of haing drug group a Chinese traditional medicine prepared herbal medicine in small pieces ready of decoction is finite liability company (the following abbreviation " company of prepared herbal medicine in small pieces ready of decoction " ) report, the result of product sampling observation that its produce does not accord with a regulation.
Announcement shows, on May 10, 2019, supervisory management board of national medicines and chemical reagents is released " the announce that does not accord with a regulation about 23 batch medicines and chemical reagents " (2019 the 22nd) , academy of calibrating of medicines and chemical reagents of classics China food examines, the juice of yew alcohol inject that biology project produces (lot number: 201709012) do not accord with a regulation, do not accord with formulary project to be imperceptible and visible eyewinker, check tastes origin to be terminal hospital.
Haing drug stock represents to this, fluid of inject of alcohol of this batch yew sheds a company to send past Hefei at carrying matter on January 18, 2018, at arriving on January 24, 2018 label closes, this batch product sent past terminal hospital on January 30, 2018, whole journey carriage temperature is highest 5.7 ℃ , lowermost temperature 4.8 ℃ . Approve according to the country and current manual regulation, taste composition to may produce precipitation originally below cold storage condition, but do not have an influence to quality of medicines and chemical reagents. Because carry temperature,this product appears to see a foreign body imperceptibly may be too low the product that cause precipitates. Biology project receives a product to examine after the report, halt the sale of this batch product instantly, according to " recall of medicines and chemical reagents runs way " requirement, all to what have not use this batch product starts recall program, this batch product sells 38 thousand in all, recall 36 thousand, undertook to recall product destroy by melting or burning is handled.
To this incident influence to the company, haing drug stock represents, 2018, fluid of yew alcohol inject year sales revenue is 5.3 million yuan, alum year sales revenue is 0, licorice (licorice piece) year sales revenue is three hundred and twenty-nine thousand four hundred yuan, areca year sales revenue is 25 thousand yuan. The proportion that afore-mentioned product sales revenue take business income of company the corresponding period is lesser, manage to the normal production of the company did not cause materiality effect.
The data shows, haing drug stock is dedicated at medical health industry, basically be engaged in medicine research and development and make, wholesale with retail trade Wu, it is collect medicine research and development, make, sell the home at an organic whole enterprise of medicine of large and new and high technology.
